Floatz logo

Therapeutic Asset Ratings

427 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Degarelix
Prostate Cancer
BayerP4BBB (72)
AVOLVE
Prostate Cancer
Masonic Cancer Center, University of MinnesotaP4BB (71)
Flotufolastat F-18
Prostate Cancer
Washington University School of MedicineP4BB (71)
Flutamide
Prostate Cancer
VA Office of Research and DevelopmentP4BB (68)
PREDNISONE TABLETS
Prostate Cancer
Mayo ClinicP4BB (68)
Zoladex
Prostate Cancer
BayerP4BB (68)
Abiraterone Acetate
Prostate Cancer
Mayo ClinicP4BB (67)
Casodex
Prostate Cancer
Washington University School of MedicineP4BB (67)
DEXAMETHASONE
Prostate Cancer
Qilu Hospital of Shandong UniversityP4BB (67)
Enzalutamide
Prostate Cancer
University of Michigan Rogel Cancer CenterP4BB (67)
LEUPROLIDE
Prostate Cancer
Mayo ClinicP4BB (67)
Zoledronate
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaP4BB (67)
NILUTAMIDE
Prostate Cancer
VA Office of Research and DevelopmentP3BB (67)
CABAZITAXEL
Prostate Cancer
Alliance for Clinical Trials in OncologyP4BB (66)
Darolutamide
Prostate Cancer
University of ChicagoP4BB (66)
Docetaxel
Prostate Cancer
National Cancer Institute (NCI)P3BB (66)
Mitoxantrone
Prostate Cancer
Shanghai Jiao Tong University School of MedicineP3BB (66)
Psma-Hbed-Cc
Prostate Cancer
University of Texas Southwestern Medical CenterP3BB (66)
Sipuleucel-T
Prostate Cancer
City of Hope Medical CenterP3BB (66)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Prostate Cancer
AstraZenecaP4BB (65)
[18f]psma-1007
Prostate Cancer
Novartis PharmaceuticalsP3BB (65)
Relugolix
Prostate Cancer
Baptist Health South FloridaP3BB (65)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Prostate Cancer
Memorial Sloan Kettering Cancer CenterP4BB (64)
Acetylsalicylic Acid
Prostate Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaP4BB (64)
Finasteride
Prostate Cancer
Turku University HospitalP4BB (64)
Showing 1 to 25 of 427 assets
PreviousPage 1 of 18Next